Tanya Warnecke is currently a partner at DVDT Partners and co-founder/ Chief Technology Officer at Codebreaker Tx. She previously spent four years as co-founder, President, Chief Technology Officer and board member at Artisan Bio, where she led all aspects of technology, intellectual property and operations to achieve Artisan’s vision to design, build and deliver precisely engineered cells for next-generation therapeutic applications. Prior to Artisan, Warnecke was co-founder, Chief Technology Officer and board member at INSCRIPTA, a start-up delivering digital genome engineering solutions including instrumentation, reagents and software for automated multiplexed CRISPR editing. She has previously served as the director of technology at OPXbio, as an advisor with the Novo Nordisk Foundation Center for Biosustain in Copenhagen, Denmark, as well as co-PI of the Cell Architecture Lab at Denmark Technical University. Warnecke is the inventor on more than 30 patent filings across a range of applications, including novel and engineered CRISPR endonucleases (MAD7) and gRNAs, CRISPR editing methods and novel targets for next-generation CRISPR-based cell therapies. She currently serves on the boards for the Colorado Biosciences Association and Sophie’s neighborhood, a nonprofit dedicated to research into cures for an ultra-rare disease.